Abbvie Inc Stock Net Income
| 4AB Stock | EUR 186.40 0.20 0.11% |
As of the 25th of January, AbbVie shows the risk adjusted performance of (0.02), and Mean Deviation of 1.24. AbbVie Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm AbbVie Inc mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if AbbVie Inc is priced correctly, providing market reflects its regular price of 186.4 per share.
AbbVie's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing AbbVie's valuation are provided below:AbbVie Inc does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. AbbVie |
AbbVie 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AbbVie's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AbbVie.
| 10/27/2025 |
| 01/25/2026 |
If you would invest 0.00 in AbbVie on October 27, 2025 and sell it all today you would earn a total of 0.00 from holding AbbVie Inc or generate 0.0% return on investment in AbbVie over 90 days. AbbVie is related to or competes with Sims Metal, Progress Software, COGNYTE SOFTWARE, Corporate Travel, OPERA SOFTWARE, AIR PRODCHEMICALS, and Unity Software. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, C... More
AbbVie Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AbbVie's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AbbVie Inc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 7.3 | |||
| Value At Risk | (2.05) | |||
| Potential Upside | 2.87 |
AbbVie Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AbbVie's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AbbVie's standard deviation. In reality, there are many statistical measures that can use AbbVie historical prices to predict the future AbbVie's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.21) | |||
| Treynor Ratio | (2.00) |
AbbVie January 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (1.99) | |||
| Mean Deviation | 1.24 | |||
| Coefficient Of Variation | (3,408) | |||
| Standard Deviation | 1.6 | |||
| Variance | 2.56 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.21) | |||
| Treynor Ratio | (2.00) | |||
| Maximum Drawdown | 7.3 | |||
| Value At Risk | (2.05) | |||
| Potential Upside | 2.87 | |||
| Skewness | 0.2346 | |||
| Kurtosis | 0.5942 |
AbbVie Inc Backtested Returns
AbbVie Inc secures Sharpe Ratio (or Efficiency) of -0.0327, which signifies that the company had a -0.0327 % return per unit of standard deviation over the last 3 months. AbbVie Inc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AbbVie's risk adjusted performance of (0.02), and Mean Deviation of 1.24 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0284, which signifies not very significant fluctuations relative to the market. As returns on the market increase, AbbVie's returns are expected to increase less than the market. However, during the bear market, the loss of holding AbbVie is expected to be smaller as well. At this point, AbbVie Inc has a negative expected return of -0.0531%. Please make sure to confirm AbbVie's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if AbbVie Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.39 |
Poor reverse predictability
AbbVie Inc has poor reverse predictability. Overlapping area represents the amount of predictability between AbbVie time series from 27th of October 2025 to 11th of December 2025 and 11th of December 2025 to 25th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AbbVie Inc price movement. The serial correlation of -0.39 indicates that just about 39.0% of current AbbVie price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.39 | |
| Spearman Rank Test | -0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 13.5 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, AbbVie Inc reported net income of 11.84 B. This is much higher than that of the Healthcare sector and 190.35% higher than that of the Drug Manufacturers - Major industry. The net income for all Germany stocks is significantly lower than that of the firm.
AbbVie Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AbbVie's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AbbVie could also be used in its relative valuation, which is a method of valuing AbbVie by comparing valuation metrics of similar companies.AbbVie is currently under evaluation in net income category among its peers.
AbbVie Fundamentals
| Return On Equity | 0.72 | |||
| Return On Asset | 0.0991 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.39 % | |||
| Current Valuation | 331.38 B | |||
| Shares Outstanding | 1.77 B | |||
| Shares Owned By Insiders | 0.12 % | |||
| Shares Owned By Institutions | 71.51 % | |||
| Price To Earning | 22.27 X | |||
| Price To Book | 18.07 X | |||
| Price To Sales | 4.72 X | |||
| Revenue | 58.05 B | |||
| Gross Profit | 41.53 B | |||
| EBITDA | 24.17 B | |||
| Net Income | 11.84 B | |||
| Cash And Equivalents | 5.23 B | |||
| Cash Per Share | 3.54 X | |||
| Total Debt | 59.13 B | |||
| Current Ratio | 1.04 X | |||
| Book Value Per Share | 9.75 X | |||
| Cash Flow From Operations | 24.94 B | |||
| Earnings Per Share | 6.25 X | |||
| Price To Earnings To Growth | 1.29 X | |||
| Target Price | 127.01 | |||
| Number Of Employees | 50 K | |||
| Beta | 0.58 | |||
| Market Capitalization | 256.3 B | |||
| Total Asset | 138.81 B | |||
| Z Score | 2.4 | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 3.39 % | |||
| Net Asset | 138.81 B | |||
| Last Dividend Paid | 5.71 |
About AbbVie Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AbbVie Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AbbVie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AbbVie Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in AbbVie Stock
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.